Literature DB >> 31287501

Outcomes after surgery for functional tricuspid regurgitation: a systematic review and meta-analysis.

Kevin M Veen1, Jonathan R G Etnel1, Thijs J M Quanjel1, Mostafa M Mokhles1, Simone A Huygens1, Moniba Rasheed1, Frans B S Oei1, Folkert J Ten Cate2, Ad J J C Bogers1, Johanna J M Takkenberg1.   

Abstract

AIMS: This study aims to provide a contemporary overview of outcomes after tricuspid valve (TV) surgery for functional tricuspid regurgitation (TR). METHODS AND
RESULTS: The literature was systematically searched for papers published between January 2005 and December 2017 reporting on clinical/echocardiographic outcomes after TV surgery for functional TR. A random effects meta-analysis was conducted for outcome variables, and late outcomes are visualized by pooled Kaplan-Meier curves. Subgroup analyses were performed for studies with a within-study comparison of suture vs. ring repair and flexible vs. rigid ring repair. Eighty-seven publications were included, encompassing 13 184 patients (mean age: 62.1 ± 11.8 years, 55% females). A mitral valve procedure was performed in 92% of patients. Pooled mean follow-up was 4.0 ± 2.8 years. Pooled early mortality was 3.9% (95% CI: 3.2-4.6), and late mortality rate was 2.7%/year (95% CI: 2.0-3.5), of which approximately half was cardiac-related 1.2%/year (95% CI: 0.8-1.9). Pooled risk of early moderate-to-severe TR at discharge was 9.4% (95% CI: 7.0-12.1). Late moderate-to-severe TR rate after discharge was 1.9%/year (95% CI: 1.0-3.5). Late reintervention rate was 0.3%/year (95% CI: 0.2-0.4). Mortality and overall (early and late) TR rate were comparable between suture vs. ring annuloplasty (14 studies), whereas overall TR rate was higher after flexible ring vs. rigid ring annuloplasty (6 studies) (7.5%/year vs. 3.9%/year, P = 0.002).
CONCLUSION: This study shows that patients undergoing surgery for functional tricuspid regurgitation (FTR) have an acceptable early and late mortality. However, TR remains prevalent after surgery. The results of this study can be used to inform patients and clinicians about the expected outcome after surgery for FTR and can results serve as a benchmark for the performance of emerging transcatheter TV interventions. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Functional tricuspid valve regurgitation; Meta-analysis; Tricuspid valve surgery

Mesh:

Year:  2020        PMID: 31287501     DOI: 10.1093/ehjqcco/qcz032

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  5 in total

1.  Combined endoscopic repair of the mitral and tricuspid valve.

Authors:  Jeffrey Shuhaiber
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 2.895

2.  Impact of 3D Rigid Ring Annuloplasty for Tricuspid Regurgitation: A Systematic Review and Meta-Analysis.

Authors:  Tao You; Yu-Hu Ma; Kang Yi; Jie Gao; Jian-Guo Xu; Xiao-Min Xu; Shao-E He; Wei Wang; Meng Ji
Journal:  Front Cardiovasc Med       Date:  2022-03-08

3.  Surgical management of tricuspid regurgitation: a new algorithm to minimise recurrent tricuspid regurgitation.

Authors:  Diego Rodriguez Torres; Lucía Torres Quintero; Diego Segura Rodríguez; Jose Manuel Garrido Jimenez; Maria Esteban Molina; Francisco Gomera Martínez; Eduardo Moreno Escobar; Rocio Garcia Orta
Journal:  Open Heart       Date:  2022-07

4.  Comparison of Hypomethylator Monotherapy with Hypomethylator plus Chemotherapy for Intermediate/High-Risk MDS or AML: A Meta-Analysis.

Authors:  Jiang Ji; Miao Chen; Bing Han
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 5.  Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?

Authors:  Marijana Tadic; Cesare Cuspidi; Daniel Armando Morris; Wolfang Rottbauer
Journal:  Heart Fail Rev       Date:  2021-07-15       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.